Published in Dig Liver Dis on October 01, 2005
Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07
Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol (2009) 1.04
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol (2008) 0.90
Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. World J Gastroenterol (2014) 0.85
Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84
Noninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertension. World J Gastroenterol (2013) 0.83
Nitric oxide levels in chronic liver disease patients with and without oesophageal varices. Hepatol Int (2008) 0.76
The Relationship between Inflammatory Marker Levels and Hepatitis C Virus Severity. Gastroenterol Res Pract (2016) 0.75
Platelet count/spleen diameter ratio: is there sufficient evidence for its use? Dig Dis Sci (2012) 0.75
Platelet Count to Spleen Diameter Ratio for the Diagnosis of Gastroesophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2017) 0.75
Can platelet count/spleen diameter ratio be used for cirrhotic children to predict esophageal varices? World J Hepatol (2016) 0.75
Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. World J Hepatol (2016) 0.75
Assessment of risk of complications in cirrhosis using portal thallium scans. World J Gastroenterol (2014) 0.75
Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage. Hepatol Int (2007) 0.75
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Safety of cold polypectomy for <10mm polyps at colonoscopy: a prospective multicenter study. Endoscopy (2011) 3.91
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
Physiology of growth and sporulation in Bacillus cereus. I. Effect of glutamic and other amino acids. J Bacteriol (1966) 2.02
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol (1997) 1.94
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J (1999) 1.92
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol (1993) 1.74
Control of the citric acid cycle by glyoxylate. Mechanism of the inhibition by oxalomalate and gamma-hydroxy-alpha-oxoglutarate. Biochem J (1967) 1.58
+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab (2008) 1.56
Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems. J Intern Med (2004) 1.53
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Influence of mastication on gastric emptying. J Dent Res (2002) 1.50
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol (1999) 1.50
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther (2004) 1.49
Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation (2000) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol (1996) 1.44
Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol (2001) 1.44
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42
[Synthesis of 3-hydrazino-pyridazines with basic substituents in 6 positions, with hypotensive activity]. Farmaco Sci (1969) 1.39
H2 antagonist and omeprazole nonresponders. Dig Dis Sci (1991) 1.39
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 1.38
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
2,6-Dialkylpiperazines. V. Synthesis of 2,6-alkylpiperazine derivatives structurally related to cinnarazine. J Med Chem (1968) 1.23
Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation (1993) 1.21
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci (1999) 1.18
Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care (1995) 1.18
Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol (2000) 1.16
A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res (2009) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer. Ann Oncol (2000) 1.13
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 1.09
Experimental atherosclerosis in the rat: biochemical evaluation. J Pharm Pharmacol (1975) 1.08
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.08
Evaluation of blood pressure/height ratio as an index to simplify diagnostic criteria of hypertension in Caucasian adolescents. J Hum Hypertens (2011) 1.08
Mean and median of pH values, characterizing average intragastric acidity. Am J Gastroenterol (1989) 1.06
Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol (2004) 1.06
Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Aliment Pharmacol Ther (2014) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab (2000) 1.05
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol (2004) 1.04
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer (2002) 1.03
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.02
Medial patellofemoral ligament anatomy: implications for its surgical reconstruction. Knee Surg Sports Traumatol Arthrosc (2009) 1.02
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology (2001) 1.00
Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features. Histol Histopathol (2012) 0.99
Acid and gastric metaplasia in the duodenum. Gut (1994) 0.98
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.98
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol (2005) 0.97
Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. J Pharmacol Exp Ther (1997) 0.96
Gastric metaplasia and Helicobacter pylori infection. Gut (1995) 0.96
Letter: biological therapies are effective for prevention of post-operative Crohn's disease recurrence. Aliment Pharmacol Ther (2014) 0.96
Design optimisation of a TOF-based collimated camera prototype for online hadrontherapy monitoring. Phys Med Biol (2014) 0.96
Effect of etanercept on insulin sensitivity in nine patients with psoriasis. Int J Immunopathol Pharmacol (2008) 0.95
Vasospastic ischemic mechanism of frequent asymptomatic transient ST-T changes during continuous electrocardiographic monitoring in selected unstable angina patients. Am Heart J (1982) 0.95
Dosimetry for treatment with radiolabelled somatostatin analogues. A review. Q J Nucl Med Mol Imaging (2010) 0.94
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Am J Gastroenterol (2000) 0.94
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther (2000) 0.93
The role of the medial ligamentous structures on patellar tracking during knee flexion. Knee Surg Sports Traumatol Arthrosc (2011) 0.92
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Fam Cancer (2012) 0.92
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil (2010) 0.92
Real-time proton beam range monitoring by means of prompt-gamma detection with a collimated camera. Phys Med Biol (2014) 0.92
13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther (2002) 0.92
A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions. Phys Med Biol (2012) 0.91
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors. Biomed Res Int (2013) 0.91